Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor
Clinical trial NCT04831320 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04831320
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2027-06-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.